India Globalization Capital (NYSE MKT: IGC) formerly mined and converted low-grade iron ore to high-grade ore until prices plummeted. It was then that company management made the decision that to preserve shareholder value it must change course.
Cannabis News
India Globalization Capital, Inc. (NYSE MKT: IGC) May Hold Blockbuster Position for Alzheimer’s Treatment
Savvy investors should be keeping a close eye on some key developments that have taken place within the past year relating to Alzheimer’s disease, medical cannabis, and India Globalization Capital (NYSE MKT: IGC)
India Globalization Capital, Inc. (NYSE: IGC) Engages a Critical Point in Cannabis History
Cannabis is now legal medically or recreationally in 28 states in the U.S., and companies such as India Globalization Capital, Inc. (NYSE MKT: IGC) are developing revolutionary cannabinoid-based combination pharmaceutical therapies.
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Findings Set Stage for Future Cannabinoid Compound Studies
InMed Pharmaceuticals, Inc.’s (CSE: IN) (OTCQB: IMLFF) study, which generated an article published in the European Journal of Pain (http://nnw.fm/SVF1j), sets the stage for more research into how a topically-applied drug can provide relief of chronic or acute pain without central side effects, according to Dr. Sazzad Hossain, chief scientific officer of InMed.
India Globalization Capital, Inc. (NYSE: IGC) Developing Phytocannabinoid-Based Product Pipeline to Treat Two- and Four-Legged Alike
Looking to gain an advantageous foothold in the burgeoning medical marijuana market, India Globalization Capital, Inc. (NYSE MKT: IGC) is developing innovative cannabis-based combination therapies that have application for both humans and animals.
India Globalization Capital, Inc. (NYSE: IGC) is “One to Watch”
India Globalization Capital, Inc. (NYSE MKT: IGC) is a first mover in developing a portfolio of products using cannabis-based “combination therapies” for the treatment of pain and other conditions.
Algae Dynamics Corp. (ADYNF) Creating a Lucrative Niche Opportunity
The fastest-growing industry with the most consistent growth rate in North America is legal marijuana. A recent Forbes article says that the market could grow 700% by 2020.
India Globalization Capital, Inc. (NYSE: IGC) From Mining to Marijuana
At first blush, India Globalization Capital (NYSE: IGC) would seem a curiosity clothed in an enigma. Just how does a NYSE company move from a successful mining orientation to a pioneer in the development of multiple cannabinoid-based pharmaceutical therapies to treat pain and disease?
India Globalization Capital (NYSE: IGC) Shows Potential for Strong Market Valuation Growth
India Globalization Capital, Inc. (NYSE MKT: IGC), a Maryland-based company, is currently preparing four products for medical trials, including Hyalolex for the treatment of Alzheimer’s disease.
Potential Blockbuster Treatment for Alzheimer’s Disease Stands Out Among Medical Cannabis Companies
Changes in public opinion regarding cannabis have greatly fueled the fire blazing under the red-hot state-legalized marijuana market.
India Globalization Capital, Inc. (NYSE: IGC) Plans to Develop Cannabinoid Extract Therapies for Cats and Dogs
IGC has filed two patents, IGC-502 and IGC-505, for combination therapies for the treatment of seizures in dogs and cats, which in it itself is a surprisingly large market.
India Globalization Capital, Inc. (NYSE: IGC) Poised to Become Phytocannabinoid Pharmaceuticals Leader
India Globalization Capital (NYSE MKT: IGC), an innovator in developing cannabis-based combination therapies to treat pain and other conditions, is currently applying the revolutionary seizure-treating potential of CBD to another population: domestic pets, and the company is addressing the 5 percent of dogs and just over 2 percent of cats in the United States that experience seizures.
The Value Drivers of InMed Pharmaceuticals, Inc. (IMLFF)
Most of the current research and development (R&D) surrounding cannabis revolves around understanding these biologically-active ingredients, especially cannabinoids.
Marijuana Market Offers Variety of Investment Options and Consistent, Long-Lasting Growth Potential
With the North American cannabis market boasting an estimated worth of $7.2 billion in 2016, and new reports projecting CAGR of between 17 percent and 25 percent within the next few years, it’s certainly an exciting time to invest in the marijuana market.
Marijuana Industry Growth Fueled by Investments and Public Support for Legalization
With the market expanding and public support increasing, there are more opportunities to invest than ever before.